[go: up one dir, main page]

FR3029114B1 - INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS - Google Patents

INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS

Info

Publication number
FR3029114B1
FR3029114B1 FR1461733A FR1461733A FR3029114B1 FR 3029114 B1 FR3029114 B1 FR 3029114B1 FR 1461733 A FR1461733 A FR 1461733A FR 1461733 A FR1461733 A FR 1461733A FR 3029114 B1 FR3029114 B1 FR 3029114B1
Authority
FR
France
Prior art keywords
symptoms
treatment
atopic dermatitis
nutritional composition
infant nutritional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1461733A
Other languages
French (fr)
Other versions
FR3029114A1 (en
Inventor
Jonathan Albert Margossian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Pharmaceuticals SA
Original Assignee
United Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Pharmaceuticals SA filed Critical United Pharmaceuticals SA
Priority to FR1461733A priority Critical patent/FR3029114B1/en
Publication of FR3029114A1 publication Critical patent/FR3029114A1/en
Application granted granted Critical
Publication of FR3029114B1 publication Critical patent/FR3029114B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR1461733A 2014-12-01 2014-12-01 INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS Active FR3029114B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1461733A FR3029114B1 (en) 2014-12-01 2014-12-01 INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1461733A FR3029114B1 (en) 2014-12-01 2014-12-01 INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS

Publications (2)

Publication Number Publication Date
FR3029114A1 FR3029114A1 (en) 2016-06-03
FR3029114B1 true FR3029114B1 (en) 2017-01-13

Family

ID=52423959

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461733A Active FR3029114B1 (en) 2014-12-01 2014-12-01 INFANT NUTRITIONAL COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS AND ITS SYMPTOMS

Country Status (1)

Country Link
FR (1) FR3029114B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3100107B1 (en) * 2019-08-28 2022-06-10 Melicerte Conseils Preparation to thicken the bolus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1070457A1 (en) * 1999-07-22 2001-01-24 Societe Des Produits Nestle S.A. Soluble composition on the basis of carob germ
JP2004107295A (en) * 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization Histamine release inhibitor
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
AR072066A1 (en) * 2008-06-06 2010-08-04 Nutricia Nv USE OF COMPOSITION THAT INCLUDES NON-DIGERABLE OLIGOSACARIDS
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
FR3005392B1 (en) * 2013-05-07 2015-09-18 United Pharmaceuticals ANTI-REGURGITATION COMPOSITION PRESERVING INTESTINAL TRANSIT

Also Published As

Publication number Publication date
FR3029114A1 (en) 2016-06-03

Similar Documents

Publication Publication Date Title
IL279752A (en) Polycyclic compounds and their use in the treatment of immune disorders
CY2024013I2 (en) USES OF IL-13 ANTAGONISTS FOR THE TREATMENT OF ATOPIC DERMATITIS
GB2551642B (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
IL249292A0 (en) Methods and devices for the treatment of pulmonary edema
IL253803B (en) Treatment of hypoparathyroidism
EP3261641A4 (en) TREATMENT OF PANCREATITIS
SG11201609652RA (en) Treatment of polybacterials infections
HUE055913T2 (en) Methods and compositions for diagnosis and treatment of glioblastoma
DK3209673T4 (en) MIXTURES OF HUMAN MILK OLIGOSACCHARIDES
EP3352586A4 (en) NUTRITIONAL ANTICANCER TREATMENT
BR112018000204A2 (en) colitis treatment methods
SG11201609993YA (en) Treatment of immune disorders
IL272949A (en) Improved treatment of atopic dermatitis with tradipitant
EP3259600C0 (en) DIAGNOSTIC ASSAY AND TREATMENT OF PREECLAMPSIA
PL3348273T3 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
EP3166477A4 (en) Systems and methods for diagnosis and treatment of swallowing disorders
EP3253395C0 (en) PROBIOTIC PREPARATION FOR THE TREATMENT OF INTESTINAL INFLAMMATION
EP3518898A4 (en) PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
EP3386507A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF GASTRIC ULCERS
IL260987A (en) Treatment and diagnosis of inflammatory disorders
FR3022139B1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA
GB201404372D0 (en) Assay and treatment
ZA201806503B (en) Treatment of canine atopic dermatitis
MA41782A (en) TREATMENT OF PATIENTS WITH TYPE 2 DIABETES
IL252779A0 (en) Prevention and treatment of inflammatory diseases

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

EXTE Extension to a french territory

Extension state: PF

PLSC Publication of the preliminary search report

Effective date: 20160603

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12